The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Regulation of the latent-lytic switch in Epstein–Barr virus
Open accessAbstract
Epstein–Barr virus (EBV) infection contributes to the development of several different types of human malignancy, including Burkitt lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma. As a herpesvirus, EBV can establish latent or lytic infection in cells. EBV-positive tumors are composed almost exclusively of cells with latent EBV infection. Strategies for inducing the lytic form of EBV infection in tumor cells are being investigated as a potential therapy for EBV-positive tumors. In this article, we review how cellular and viral proteins regulate the latent-lytic EBV switch in infected B cells and epithelial cells, and discuss how harnessing lytic viral reactivation might be used therapeutically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Epstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
Histone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Feederle, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.3080 · Cited by 387
Postigo, A. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg226 · Cited by 387
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Skalsky, R. L., Corcoran, D. L., Gottwein, E., Frank, C. L., Kang, D., Hafner, M., Nusbaum, J. D., Feederle, R., Delecluse, H.-J., Luftig, M. A., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002484 · Cited by 352
Synchronous and sequential activation of latently infected Epstein-Barr virus genomes
Takada, K., & Ono, Y. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.445-449.1989 · Cited by 331
Viral Latency and Its Regulation: Lessons from the γ-Herpesviruses
Speck, S. H., & Ganem, D. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.014 · Cited by 302
Perrine, S. P., Hermine, O., Small, T., Suarez, F., O'Reilly, R., Boulad, F., Fingeroth, J., Askin, M., Levy, A., Mentzer, S. J., et al. (2007) · Blood · doi:10.1182/blood-2006-01-024703 · Cited by 297
EBV and human microRNAs co‐target oncogenic and apoptotic viral and human genes during latency
Riley, K. J., Rabinowitz, G. S., Yario, T. A., Luna, J. M., Darnell, R. B., & Steitz, J. A. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.63 · Cited by 282
Zalani, S., Holley-Guthrie, E., & Kenney, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9194 · Cited by 227
Self-citationEpstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model
Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13993-14003.2005 · Cited by 225
Self-citationReactivation of Epstein-Barr virus from latency
Amon, W., & Farrell, P. J. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.456 · Cited by 223
Crook, T., Nicholls, J. M., Brooks, L., O'Nions, J., & Allday, M. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203656 · Cited by 194
The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome
Bhende, P. M., Seaman, W. T., Delecluse, H.-J., & Kenney, S. C. (2004) · Nature Genetics · doi:10.1038/ng1424 · Cited by 192
Self-citationAdamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J., & Kenney, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1224-1233.2000 · Cited by 184
Self-citationKalla, M., Schmeinck, A., Bergbauer, M., Pich, D., & Hammerschmidt, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911948107 · Cited by 166
Meng, Q., Hagemeier, S. R., Fingeroth, J. D., Gershburg, E., Pagano, J. S., & Kenney, S. C. (2010) · Journal of Virology · doi:10.1128/jvi.02487-09 · Cited by 162
Self-citationCyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
Tsang, C. M., Yip, Y. L., Lo, K. W., Deng, W., To, K. F., Hau, P. M., Lau, V. M. Y., Takada, K., Lui, V. W. Y., Lung, M. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202637109 · Cited by 159
Matthews, S. A., Liu, P., Spitaler, M., Olson, E. N., McKinsey, T. A., Cantrell, D. A., & Scharenberg, A. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1569-1577.2006 · Cited by 150
Bhende, P. M., Dickerson, S., Sun, X., Feng, W., & Kenney, S. C. (2007) · Journal of Virology · doi:10.1128/jvi.00154-07 · Cited by 141
Self-citationLiu, S., Liu, P., Borras, A. M., Chatila, T. A., & Speck, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.143 · Cited by 140
Histone Acetylation and Reactivation of Epstein-Barr Virus from Latency
Jenkins, P. J., Binné, U. K., & Farrell, P. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.710-720.2000 · Cited by 133
Sun, C. C., & Thorley‐Lawson, D. A. (2007) · Journal of Virology · doi:10.1128/jvi.01055-07 · Cited by 132
Feng, W., & Kenney, S. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1006 · Cited by 124
Self-citationCpG-Methylation Regulates a Class of Epstein-Barr Virus Promoters
Bergbauer, M., Kalla, M., Schmeinck, A., Göbel, C., Rothbauer, U., Eck, S. H., Benet‐Pagès, A., Strom, T. M., & Hammerschmidt, W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001114 · Cited by 119
Hong, G. K., Kumar, P., Wang, L., Damania, B., Gulley, M. L., Delecluse, H., Polverini, P. J., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13984-13992.2005 · Cited by 116
Self-citationGruffat, H., Manet, É., & Sergeant, A. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf031 · Cited by 114
Darr, D., Mauser, A., & Kenney, S. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6135-6142.2001 · Cited by 107
Self-citationVirally targeted therapies for EBV-associated malignancies
Israel, B. F., & Kenney, S. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206548 · Cited by 106
Self-citationA network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells
Yu, J., Baron, V. T., Mercola, D., Mustelin, T., & Adamson, E. D. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402029 · Cited by 101
Structural Basis of Lytic Cycle Activation by the Epstein-Barr Virus ZEBRA Protein
Petosa, C., Morand, P., Baudin, F., Moulin, M., Artero, J.-B., & Müller, C. W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.006 · Cited by 99
Vrzalikova, K., Vockerodt, M., Leonard, S. M., Bell, A. I., Wei, W., Schrader, A., Wright, K. L., Kube, D., Rowe, M., Woodman, C. B. J., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307710 · Cited by 97
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors
Fu, D.-X., Tanhehco, Y. C., Chen, J., Foss, C. A., Fox, J. J., Chong, J. M., Hobbs, R. F., Fukayama, M., Sgouros, G., Kowalski, J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1864 · Cited by 92
Ragoczy, T., & Miller, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5240-5251.2001 · Cited by 91
ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
Yu, X., Wang, Z., & Mertz, J. E. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030194 · Cited by 89
Self-citationBhende, P. M., Seaman, W. T., Delecluse, H., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7338-7348.2005 · Cited by 89
Self-citationEllis-Connell, A. L., Iempridee, T., Xu, I., & Mertz, J. (2010) · Journal of Virology · doi:10.1128/jvi.00923-10 · Cited by 88
Self-citationHagemeier, S. R., Barlow, E. A., Meng, Q., & Kenney, S. C. (2012) · Journal of Virology · doi:10.1128/jvi.01850-12 · Cited by 87
Self-citationHypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle
Jiang, J. H., Wang, N., Li, A., Liao, W., Pan, Z.-G., Mai, S., Li, D.-J., Zeng, M., Wen, J., & Zeng, Y.-X. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.06.013 · Cited by 81
γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis
Zhu, Y., Häecker, I., Yang, Y., Gao, S., & Renne, R. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.05.013 · Cited by 78
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Roychowdhury, S., Peng, R., Baiocchi, R. A., Bhatt, D., Vourganti, S., Grecula, J. C., Gupta, N., Eisenbeis, C. F., Nuovo, G. J., Yang, W., et al. (2003) · PubMed · Cited by 78
Liang, C.-L., Chen, J.-L., Hsu, Y. P., Ou, J. T., & Chang, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107420200 · Cited by 74
The role of microRNAs in Epstein-Barr virus latency and lytic reactivation
Forte, E., & Luftig, M. A. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.07.007 · Cited by 74
Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1
Li, C., Chung, J.-Y., Hong, Y.-R., Ichimura, T., Nakao, M., & Liu, S.-T. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki956 · Cited by 73
Bryant, H. E., & Farrell, P. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10290-10298.2002 · Cited by 70
Ellis-Connell, A. L., Zhenxun, W., Yu, X., & Mertz, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.02706-09 · Cited by 68
Self-citationmiRNAs in the pathogenesis of oncogenic human viruses
Lin, Z. N., & Flemington, E. K. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.08.018 · Cited by 62
Hong, G. K., Delecluse, H., Gruffat, H., Morrison, T. E., Feng, W.-H., Sergeant, A., & Kenney, S. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.4983-4992.2004 · Cited by 60
Self-citationEpigenetic regulation of EBV and KSHV latency
Chen, H.-S., Lu, F. Y., & Lieberman, P. M. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.004 · Cited by 59
Iempridee, T., Das, S., Xu, M., & Mertz, J. E. (2011) · Journal of Virology · doi:10.1128/jvi.01197-10 · Cited by 56
Self-citationLin, Z. N., Wang, X., Fewell, C., Cameron, J. E., Yin, Q., & Flemington, E. K. (2010) · Journal of Virology · doi:10.1128/jvi.00379-10 · Cited by 55
Daigle, D., Gradoville, L., Tuck, D. P., Schulz, V., Wang’ondu, R. W., Ye, J., Gorres, K. L., & Miller, G. (2011) · Journal of Virology · doi:10.1128/jvi.02659-10 · Cited by 54
The Epstein-Barr Virus LF2 Protein Inhibits Viral Replication
Calderwood, M. A., Holthaus, A. M., & Johannsen, E. (2008) · Journal of Virology · doi:10.1128/jvi.00315-08 · Cited by 52
Quiñones, A., Dobberstein, K.-U., & Rainov, N. G. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00230-3 · Cited by 47
Davies, M. L., Xu, S., Lyons‐Weiler, J., Rosendorff, A., Webber, S. A., Wasil, L. R., Metes, D., & Rowe, D. (2010) · Virology · doi:10.1016/j.virol.2010.01.002 · Cited by 46
Genome-Wide Analysis of Epstein-Barr Virus Rta DNA Binding
Heilmann, A. M. F., Calderwood, M. A., Portal, D., Lu, Y. C., & Johannsen, E. (2012) · Journal of Virology · doi:10.1128/jvi.06760-11 · Cited by 41
Ramasubramanyan, S., Kanhere, A., Osborn, K., Flower, K. J., Jenner, R. G., & Sinclair, A. J. (2012) · Journal of Virology · doi:10.1128/jvi.01705-12 · Cited by 38
Hagemeier, S. R., Barlow, E. A., Kleman, A. A., & Kenney, S. C. (2011) · Journal of Virology · doi:10.1128/jvi.01856-10 · Cited by 37
Self-citationCritical Role of p53 in Histone Deacetylase Inhibitor-Induced Epstein-Barr Virus Zta Expression
Chang, S.-S., Lo, Y., Chua, H., Chiu, H., Tsai, S., Chen, J., Lo, K. W., & Tsai, C.-H. A. (2008) · Journal of Virology · doi:10.1128/jvi.02717-07 · Cited by 36
Jang, E. R., Choi, J. D., Park, M. A., Jeong, G., Cho, H., & Lee, J. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.3.020 · Cited by 34
Heather, J., Flower, K. J., Isaac, S. J., & Sinclair, A. J. (2009) · Journal of General Virology · doi:10.1099/vir.0.007922-0 · Cited by 33
Yu, X., McCarthy, P. J., Wang, Z., Gorlen, D. A., & Mertz, J. E. (2012) · Journal of Virology · doi:10.1128/jvi.00234-12 · Cited by 26
Self-citationYe, J., Gradoville, L., & Miller, G. (2010) · Journal of Virology · doi:10.1128/jvi.01415-10 · Cited by 25
Epstein-Barr Virus Utilizes Ikaros in Regulating Its Latent-Lytic Switch in B Cells
Iempridee, T., Reusch, J. A., Riching, A. S., Johannsen, E., Dovat, S., Kenney, S. C., & Mertz, J. E. (2014) · Journal of Virology · doi:10.1128/jvi.03706-13 · Cited by 23
Self-citationBuettner, M. J., Lang, A., Tudor, C. S., et al. (2012) · Journal of General Virology · doi:10.1099/vir.0.038661-0 · Cited by 23
El-Guindy, A. S., Heston, L., Delecluse, H., & Miller, G. (2007) · Journal of Virology · doi:10.1128/jvi.02445-06 · Cited by 23
Yu, K.-P., Heston, L., Park, R., Ding, Z., Wang’ondu, R. W., Delecluse, H., & Miller, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301577110 · Cited by 22
Cited by
Epstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
Self-citationThe role of Epstein–Barr virus in epithelial malignancies
Tsao, S., Tsang, C. M., To, K., & Lo, K. (2015) · The Journal of Pathology · doi:10.1002/path.4448 · Cited by 337
EBV Persistence—Introducing the Virus
Thorley-Lawson, D. A. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_8 · Cited by 333
Transforming Growth Factor Beta (TGF-β) in Adolescent Chronic Fatigue Syndrome
Wyller, V. B., Nguyen, C. B., Ludviksen, J. A., & Mollnes, T. E. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1350-1 · Cited by 20
Metadata
- Authors
- Kenney, S. C., & Mertz, J. E.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 26
- Pages
- 60-68
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2015616819
- Cited by
- 281
- References
- 69
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.